Drug Profile
Asapiprant - BioAge Labs
Alternative Names: BGE-175; S-555739Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Shionogi
- Developer BioAge Labs; Shionogi
- Class Acetic acids; Antiallergics; Antivirals; Oxazoles; Piperazines; Small molecules
- Mechanism of Action Prostaglandin D2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II COVID 2019 infections
- Discontinued Allergic rhinitis